SC
IFRX icon

Stempoint Capital’s InflaRx IFRX Stock Holding History

Stempoint Capital’s Portfolio IFRX Stock Details IFRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.23M Buy
+3,228,255
New +$6.07M 1.25% 26
2025
Q2 		– Sell
-725,019
Closed -$740K – 67
2025
Q1 		$740K Buy
+725,019
New +$1.37M 0.24% 47

Other funds holding IFRX

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

Stempoint Capital's IFRX Position: Q2 2026 in Review

Stempoint Capital opened a new position in InflaRx (IFRX) in Q2 2026: 3,228,255 shares worth $7.23M. The stake represents 1.25% of the portfolio and ranks #26 among its holdings. This is a return to the name: Stempoint Capital previously reported a position in IFRX as recently as Q1 2025.

Stempoint Capital first reported a position in IFRX in Q1 2025 and has held it in 2 quarters since. 62 funds tracked by Wall St. Rank hold IFRX as of Q2 2026.

  • Stempoint Capital held 3,228,255 shares of InflaRx worth $7.23M as of Q2 2026.
  • InflaRx was a new Stempoint Capital position in Q2 2026.
  • InflaRx made up 1.25% of Stempoint Capital's portfolio in Q2 2026, its #26 holding.
  • Stempoint Capital first reported a position in InflaRx in Q1 2025 and has held it in 2 quarters since.
  • 62 funds tracked by Wall St. Rank held InflaRx as of Q2 2026.

Based on Stempoint Capital's 13F filing for Q2 2026, filed 14 Aug 2026.